RELIEF: Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease (clinicaltrials.gov) - Feb 5, 2024 - P2 | N=120 | Active, not recruiting | Sponsor: Oculis | Recruiting ➔ Active, not recruiting
Enrollment closed • Dry Eye Disease • Ophthalmology
|